Fimasartan and Rosuvastatin
BR-FRC-CT-301
Phase 3 small_molecule completed
Quick answer
Fimasartan and Rosuvastatin for Essential Hypertension, Dyslipidemia is a Phase 3 program (small_molecule) at Yung NA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Yung NA
- Indication
- Essential Hypertension, Dyslipidemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed